Patients without PVT n (%) 120 (80.5%) | Patients with PVT n (%) 29 (19.5%) | p-value | |
---|---|---|---|
Gender F/Ma | 49 (32.9%)/70 (47%) | 11 (7.4%)/18 (12.7%) | 0.100 |
Age (years)b | 50.9 ± 17.0 | 56.8 ± 17.1 | 0.070 |
Body Mass Index (kg/m2)b | 24.8 ± 5.1 | 25.6 ± 4.7 | 0.511 |
Thromboembolic medical historya | 3 (2.5%) | 1 (3.4%) | 0.580 |
Curative anticoagulant therapya | 4 (3.3%) | 1 (3.4%) | 0.670 |
Portal hypertensiona | 2 (1.7%) | 1 (3.4%) | 0.480 |
Indications: a | |||
Splenic trauma | 45 (37.5%) | 0 (0%) | < 0.001 |
Malignant haemopathies | 24 (20%) | 16 (55.2%) | < 0.001 |
Lymphoma | 8 (6.7%) | 15 (51.7%) | < 0.001 |
Contiguity | 27 (22.5%) | 5 (17.2%) | 0.210 |
ITP | 11 (9.2%) | 2 (6.9%) | 0.570 |
Others | 13 (10.8%) | 6 (20.7%) | 0.162 |
Pre-operative laboratory testsc | |||
Haemoglobin (g/dL) | 11.8 (8.8–14.3) | 11.3 (9.7–12.8) | 0.380 |
Leukocytes (G/L) | 11.9 (6.1–15.4) | 15.0 (20.6–5.25) | 0.160 |
Platelets (G/L) | 197.1 (175–215) | 146.1 (103–188) | 0.050 |
Prothrombin (%) | 80.1 (66.2–96.4) | 86.4 (80.3–93.8) | 0.060 |
Transfusiona | 57 (47.5%) | 7 (24.1%) | 0.051 |
Per-operative conditions | |||
OS/LS | 101 (84.2%)/19 (15.8%) | 25 (86.2%)/4 (13.8%) | 0.310 |
Duration of surgery (min)b | 130.7 ± 127.9 | 147.6 ± 129.8 | 0.541 |
Splenic weight (g) c | 413.7 (307.2–520.3) | 1468.6 (1036.9–1900.2) | < 0.00001 |
Post-operative PVT symptomsa | 64 (53.8%) | 9 (31.0%) | 0.028 |